Generic drug from Alostil
Therapeutic class: Dermatology
active ingredients: Minoxidil
laboratory: Pierre Fabre Dermatology
Box of 1 bottle with graduated pipette and 60 ml dosing pump
All forms
Indication
Androgenetic alopecia of moderate intensity in humans.
Note: This drug is not recommended in women because of its low efficacy and the high frequency of hypertrichosis (37% of cases) away from the application sites.
Dosage ALOPEXY 5% Solution for cutaneous application Box of 1 Bottle with graduated pipette and dosing pump of 60 ml
Dermal.
Apply 2 times a day a dose of 1 ml on the scalp starting from the center of the area to be treated. This dose must be respected regardless of the extent of the area concerned.
The daily dose should not exceed 2 ml.
Spread the product with the fingertips to cover the entire area to be treated.
Before and after application of the solution, wash hands thoroughly.
Apply on hair and scalp perfectly dry.
Do not apply on another part of the body.
A treatment lasting 2 months at a rate of 2 applications per day may be necessary before being shown stimulation of hair growth. The beginning and the degree of the response are variable from one patient to another.
However, some data suggest that the youngest users whose baldness has started more recently or whose baldness on the crown of the skull is less extensive, respond better to the treatment. Individual responses to treatment are not predictable.
According to some observations, a return to the initial state would appear in 3 or 4 months in case of discontinuation of treatment.
This medication should not be used in children under 18 years of age due to the lack of data on safety and efficacy.
Using the pipette
A pipette can accurately collect 1 ml of solution to be distributed over the entire area to be treated.
Using the pump with applicator
Remove the bottle cap and unscrew the cap that closes the bottle.
Adapt by screwing the dosing pump to the bottle.
For the application: direct the pump towards the center of the area to be treated, press once and spread the product with the fingertips to cover the entire area to be treated. Repeat the procedure 6 times to apply a dose of 1 ml.
Rinse the cannula with hot water after each use.
Against indications
· Hypersensitivity to the active substance or to any of the excipients.
· Pathological scalp.
· Poor form tolerance at 2% regardless of symptomatology.
Efficacy and safety in subjects under 18 years of age and over 65 years of age have not been studied.
Alopexy side effects
The adverse effects and their frequency were determined from a randomized, double-blind, placebo-controlled clinical trial with 393 patients comparing minoxidil 5% (157 patients) to minoxidil 2% (158 patients) and placebo (78 patients). . The frequencies of adverse reactions reported during the marketing of minoxidil in dermal application are unknown. Adverse reactions are listed by organ system class and frequency using the following classification: Very common (≥ 1/10); frequent (≥ 1/100; <1/10); uncommon (≥ 1/1000; <1/100); rare (≥ 1/10 000, <1/1000), very rare (<1 / 10, 000).
It is most commonly minor skin reactions.
Infections and Infestations | |
Frequency unknown | Ear infection |
Otitis externa | |
rhinitis | |
Immune system disorders | |
Frequency unknown | hypersensitivity |
Nervous system disorders | |
Frequent (≥ 1/100, <1/10) | headaches |
Frequency Unknown | Neuritis |
tingling | |
dysgeusia | |
Burning sensation | |
Eye disorders | |
Frequency Unknown | Blurry vision |
Eye irritation | |
Affections of the ear and labyrinth | |
Frequency Unknown | Fear of heights |
Cardiac disorders | |
Frequency Unknown | tachycardia |
Vascular disorders | |
Frequency Unknown | hypotension |
Hepatobiliary disorders | |
Frequency Unknown | Hepatitis |
Skin and subcutaneous tissue disorders | |
Very common (in women) (≥ 1/10) | Hypertrichosis (remote) |
Frequent (≥ 1/100, <1/10) | Contact eczema (due to the presence of propylene glycol) |
Frequency Unknown | Generalized erythema |
Skin rash | |
Alopecia | |
Abnormal texture of hair | |
Renal and urinary disorders | |
Frequency Unknown | nephrolithiasis |
General disorders and administration site conditions | |
Frequent (≥ 1/100, <1/10) | Application site reaction: irritation, exfoliation, dermatitis, erythema, dryness, pruritus |
Frequency Unknown | Edema of the face |
Edema | |
Asthenia | |
Chest pain |
Frequent skin applications can cause irritation and dryness of the skin due to the presence of ethanol.